About Us

Who We Are

We provide biomanufacturing strategy and execution to startup and established pharmaceutical companies, advanced therapy companies, academia, hospitals, government agencies, financial institutions, CROs/CMOs, not-for-profit organizations and medical device companies. Our services include turnkey capital projects, tech transfers and facility builds; owner's representation; project and program management; validation; quality, regulatory and compliance; engineering and automation; serialization / track and trace; reliability, compliance and asset management; and more. We are committed to advancing manufacturing to achieve operational excellence and accelerate speed to market for next-generation medicines.

 

 

Contact Us

 

FOOTPRINT, TEAM & CULTURE

Our Team

Our strategy is to hire, train and develop full-time employees, not temporary or 1099 contractors, that become the backbone of our company. We boast an extremely low employee turnover rate and high Glassdoor rating.

Our Culture

We foster a collaborative environment that promotes an engaging culture among our team members and clients. As a result, our team is able to overcome obstacles and provide exceptional project delivery. Our Glassdoor reviews boast of a “team-oriented nurturing environment” that “stresses a culture that is inclusive” and “values people and maintains a patient-focused mentality.”

Patient Focused

We named our firm “Project Farma” to remind our team why they come to work every day: for the patients. We believe that having a focus on philanthropy and connecting our team to the patients allows for a culture focused on providing solutions, meeting deadlines & getting results.

PF CARES

We are driven by our C.A.R.E.S. philosophy - Culture Focused, Agile Integration, Results Driven, Execution Excellence, Strategic Partnerships. It is our foundation for providing exceptional service and results that are required by our trusted partners. Our CARES philosophy focuses on the value of our partnerships and our team members. It is the foundation for our and our partners' success.

Diversity

We value the diversity of our team members and their unique perspectives and experiences. Diversity is not only age, race, sex, sexual orientation, military status, disabilities, and ethnicity but also geographic locations, clients and their respective markets, roles and responsibilities, job functions, and educational background. By valuing these differences, we evolve and successfully demonstrate our commitment to our CARES philosophy and treating everyone with fairness and respect.

Results & Efficiency

As a result of our culture and philosophy, Project Farma provides a motivated project delivery team that has a track record of creating 5-15% efficiency savings, limiting scope creep and delivering projects on time and on budget.


Philanthropy

Philanthropy is Built
into our Foundation

As a patient-focused delivery team, we are committed to connecting our team members to patients and their families. Connecting our team to the patients has fostered a culture within our organization that is focused on providing solutions, meeting deadlines and getting results.

Learn More
PF Team

Project Farma Leadership Team

Anshul Mangal

Anshul Mangal

Co-Founder & President

Anshul Mangal

Co-Founder & President

Anshul founded and steered PF to become a prominent global consultancy specializing in biologics and advanced therapy engineering with 200+ professionals. Anshul’s role extends to overseeing all corporate legal matters as General Counsel. Under Anshul’s guidance, PF pioneered the industrialization of groundbreaking therapeutics, including some of the earliest commercially approved cell and gene therapies, radioligand treatments, RNA-based therapies, and cutting-edge biologics. Additionally, Anshul led PF in acquiring and conducting due diligence on other engineering consulting firms, bolstering the company’s ability to offer comprehensive solutions to drug developers facing manufacturing and technical challenges. PF’s recent achievements include leading 50+ facility builds with a total capital investment exceeding $5 billion, managing 200+ capital projects, and collaborating with 100+ life science companies.

In 2020, Precision Medicine Group acquired PF, making it the cornerstone of Precision ADVANCE. ADVANCE is a collection of services within Precision, uniquely focused on addressing the intricate aspects of research, clinical development, regulatory compliance, manufacturing, and commercialization required to successfully bring complex, innovative therapies to market. Anshul’s commitment to advancing next-generation medicines extends to various boards and philanthropic organizations, including IQHQ, Alliance for Regenerative Medicines, Alliance for mRNA Medicines, Institute for Life Changing Medicines and several patient-advocacy organizations.

Before his tenure at PF, Anshul was an attorney and founded several digital agencies. He was a patent litigator at Jones Day and dedicated pro bono work to help persecuted refugees attain asylum in the United States. He graduated from Purdue University with a Bachelor’s in Computer and Electrical Engineering and earned his law degree from John Marshall Law School. During law school, he clerked for a federal judge in the Northern District of Illinois and was Editor-in-Chief of the Review of Intellectual Property Law.


Tony Khoury

Tony Khoury

Executive Vice President

Tony Khoury

Executive Vice President

Tony Khoury is an experienced executive in the life sciences sector with a focus on biologics and advanced therapies. Tony actively serves on multiple boards including academic, philanthropic, biotech and financial investment institutions.

As a member of the Project Farma and Precision for Medicine executive leadership teams, Tony has spearheaded the firm’s growth in the biotech space with a focus on next generation medicines. Tony has extensive experience across multiple modalities including solid oral dosage, biologics, bio-therapies, RNA, radioligand therapy, cell therapy, and gene therapy & editing working with established biotech companies, startups, academic centers, financial institutions and CMOs/CROs. He has led global programs deploying billions in capital across the life sciences sector and the following disciplines: business and technical operations, organizational establishment, program management, facility builds, CDMOs and critical GMP supplier partnerships, automation, AI and ML, validation, reliability and maintenance, quality, supply chain, and serialization track and trace.

Tony has supported pioneering the industrialization of next generation medicines including many of the first FDA-approved advanced therapies and led the creation of Project Farma’s Advanced Therapy Manufacturing Playbook which has helped develop the largest advanced therapy manufacturing footprints in the world.


John Khoury

John Khoury

Co-Founder & Executive Vice President

John Khoury

Co-Founder & Executive Vice President

John Khoury is a seasoned executive and entrepreneur, biologics and advanced therapy expert with a passion for operational leadership and philanthropic impact.

John is the co-founder and EVP of Project Farma (PF), a leading global biologics and advanced therapy engineering consulting firm. His work with PF has been instrumental in industrializing the largest cell and gene therapy manufacturing footprints in the world, and the commercialization of two of the most notable FDA-approved advanced therapies. In totality, he has overseen 50+ facility builds with over $5BB in capital spend, the selection and management of 80+ CDMOs, and facilitated partnerships with 100+ life science organizations including startups, established biologics and cell and gene innovators.

In 2021, Project Farma was acquired by Precision Medicine Group (PMG). John has maintained his role as Executive Vice President strategically spearheading major initiatives for the 200+ team members including organizational structure, finance, marketing, human resources, and growth while maintaining Project’s Farma’s “Patient Focused, People First” core values.

Prior to Project Farma, John started several B2B and B2C companies in the financial, real estate, manufacturing, and consulting sectors. Over a 10-year period, his business acumen and drive facilitated international growth opportunities in the US, EU, Middle East, and China. John is also a champion for patient advocacy and philanthropy. As a philanthropic and servant leader, John has led his team to volunteer 7,000+ hours over the past few years in support of 25+ patient advocacy groups and not-for-profit organizations.


Chad Salisbury

Chad Salisbury

Sr. Vice President

Chad Salisbury

Sr. Vice President

Chad Salisbury joined Project Farma in October 2022 as Senior Vice President. Chad has over 20 years of experience encompassing gene therapy, vaccines, sterile injectables and small molecules, including the delivery of ~$2B USD of greenfield cGMP manufacturing facilities.  Chad has held increasingly responsible management positions in manufacturing, quality, engineering and supply chain.

Chad was most recently VP, Manufacturing at Affinia Therapeutics, a company singularly focused on using innovations in gene therapy to lead the fight against devastating rare and prevalent diseases.  Prior to Affinia, Chad held progressive roles at CSL Seqirus, Novartis and Eli Lilly in both the US and Europe.

Chad holds an MBA from Purdue University, an MEM from Duke University and a B.A. from Alfred University.


Greg Gara

Greg Gara

Sr. Vice President

Greg Gara

Sr. Vice President

Greg has over 30 years of industry experience in biotechnology, most recently focused on gene therapy.  His experience encompasses designing, constructing, start up and licensure of manufacturing facilities around the globe.  He has held positions of increasing management and leadership responsibility across TechOps/CMC including roles in manufacturing, engineering, quality, and program management, both at site and global levels.

Greg has a degree in Biology and Environmental Science from Augusta College.


Adam Pfeiffer

Adam Pfeiffer

Vice President

Adam Pfeiffer

Vice President

In his role, Adam drives overall business strategy, aligning with operations, marketing, and business development groups in growing the firm’s global life sciences partnerships.

With 20+ years of life sciences consulting experience, Adam has supported countless drug manufacturers in bringing life-saving therapies to the market, with an emphasis on engineering and qualification in the advanced therapy and large-molecule biologics space. He has a degree in Chemical Engineering from Colorado State University.


Jacob Greenwood

Jacob Greenwood

Vice President

Jacob Greenwood

Vice President

Jacob Greenwood has spent his 15+ year professional career working in the Life Sciences industry. At Project Farma, Jacob is a strategic leader, creating and fostering client relationships and building brand awareness within the pharmaceutical and biotech industries.

In addition to his experience with Project Farma, Jacob spent 5 years as a business development professional within the Architecture, Engineering, and Construction industry, delivering projects totaling nearly $500M.  Prior to developing his sales career, he was an active member of the preclinical research community, managing vivariums in both Maryland and North Carolina. Jacob remains committed to helping medicines and therapies move through the research and development stage into manufacturing and ultimately into a position to positively impact the lives of patients.


Jim Watson

Jim Watson

Vice President

Jim Watson

Vice President

Jim has 25+ years of experience in the pharmaceutical industry. He is a Vice President at Project Farma, has led development of Project Farma’s presence in the East Coast, and been a leader on its cell and gene therapy task force.

He started his career designing, building, and starting up membrane plants supporting various industries, and eventually moved into the management of large scale capital projects in life science as well as leading engineering, maintenance, capital programs and EHS disciplines at a leading CMO.  Jim has recently led multiple operational and commercial readiness programs.  Jim has extensive experience in high purity utilities, large molecule biological processes and advanced therapies.  He has worked for small and established pharmaceutical and biotech organizations launching early phase manufacturing strategy, conceptual design, user requirement specifications, verification, validation, facility turnover and facility operations.

Jim graduated with a BS in Chemical Engineering with Biomedical Interests from Worcester Polytechnic Institute and is completing an MBA through the University of Central Oklahoma.


Kathy Johnson

Kathy Johnson

Director of Human Resources

Kathy Johnson

Director of Human Resources

Kathy Johnson is the Director of Human Resources at Project Farma. With over 14 years of professional HR experience encompassing a wide variety of industries,  Kathy leads with a “People First” mentality and is responsible for ensuring the strategic goals of the business align with employee initiatives across the organization. Specific areas of support include resourcing, talent management, performance management and employee engagement and retention.


Sarah Stoll

Sarah Stoll

Sr. Director

Sarah Stoll

Sr. Director

Sarah Stoll is a Director at Project Farma. She has over 8 years of experience in capital projects, operational strategy and execution in the Pharmaceuticals, Biotechnology and Gene Therapy Industry. In her role, Sarah applies expert knowledge, industry experience, and relentless energy to resolve potential roadblocks and produce solutions. She has led diverse, cross-functional teams of up to 25 throughout the entire project lifecycle including project initiation/funding requests, business case development, conceptual design, basis of design, detailed design, construction, commissioning and qualification, validation, project close-out/purchase order closure. She has a degree in B.S in Chemical and Biological Engineering from the University of Colorado at Boulder 


Scott Deckrow

Scott Deckrow

General Manager of Business Operations

Scott Deckrow

General Manager of Business Operations

Scott Deckrow is the General Manager of Business Operations at Project Farma. Scott has 20+ years of Business management experience spanning multiple sectors from biotech / pharmaceutical to E-commerce and big box retail. As a member of Project Farma team, Scott has helped develop and enhance the strategic direction for Human Resources, Accounting, and Finance as well as bringing operational support to all PF’s regional teams. 


Joseph Neroni

Joseph Neroni

Sr. Director

Joseph Neroni

Sr. Director

Joe Neroni is a Director at Project Farma. He is a 10+ year leader in the biologics and advanced therapies industry leading and supporting cross-functional teams in Capital Projects, Medical Device, Engineering, and Validation in the Pharmaceutical, Biotechnology and Gene & Cell Therapy Industry, and Aerospace industries. As a member of the Project Farma Team, Joe has helped Project Farma’s growth in the gene and cell therapy space including building gene therapy facilities for some of the first ever commercially approved therapies. 

He has worked with small and large biotech companies including gene and cell therapy startups and CMOs/CROsholding multiple roles ranging in a wide variety of scope and responsibility from Project Management, Engineering Technical Lead, and Commissioning and Qualification Lead for Gene and Cell Therapy Facility Builds, Medical Device, Business Strategy, Technical Operations advisement and Facility Remediation. Joe has led programs greater than $230MM in the following disciplines: program and project management, turnkey facility builds, automation, validation, and engineering. He brings a strong technical background in Upstream, Downstream and Fill and Finish processes through the project life cycle from conceptual design through implementation with a proven adaptability to new situations demonstrated by successful projects in a variety of companies and industries involving new or improved facilities, infrastructure, utilities and process equipment.   


Michelle Sinsel

Michelle Sinsel

Sr. Director

Michelle Sinsel

Sr. Director

Michelle Sinsel is a Director at Project Farma. In her role, Michelle leads high performing CQV teams, mentors and develops peers, creates validation strategies for projects, SME for data integrity initiatives, and manages project accounts for Project Farma.

With over 20+ years of extensive validation experience, Michelle brings significant validation and project knowledge to Project Farma. She has worked across the industry as a data integrity SME and validation manager with two brownfield startups, numerous process validation and data integrity remediations, and site expansions. Michelle specializes in computer system validations, QC instrument qualification, data integrity solutions, and equipment qualification.


Phil Massey

Phil Massey

Sr. Director

Phil Massey

Sr. Director

Phil Massey is a Director at Project Farma. In his role, Phil manages a multitude of clients throughout the Midwest region, leading integrated teams in biologics, blood therapies and next generation medicines (cell and gene therapies). Additionally, Phil leads several task forces focused on technical strategy and execution related to compliant pre-clinical, clinical, and commercial manufacturing.

Beginning his career at Pfizer in Australia, Phil moved into life sciences consulting, providing technical and managerial leadership to agile teams across a range of functional areas such as project management, facilities, infrastructure, process equipment, manufacturing operations and quality projects. His recent experience with PF includes building technical operations programs for some of the first ever commercially approved therapies as well as some exciting and promising pre-clinical therapies in the US and UK. He has an Economics and Communications Degree from Macquarie University in Sydney, Australia. 


Cory Proctor

Cory Proctor

Sr. Director

Cory Proctor

Sr. Director

Cory Proctor is a Director at Project Farma. He has 10+ years of experience in capital projects, medical device, and validation in the Pharmaceuticals, Biotechnology and Gene Therapy industry. Cory has held multiple project lead roles with the most recent being Project Manager for a gene therapy Tech Transfer. He has led diverse, cross-functional teams throughout the entire project lifecycle including project initiation/funding requests, business case development, conceptual design, basis of design, detailed design, construction, commissioning/qualification, validation, project close-out/purchase order closure. 


Landon DeCosta

Landon DeCosta

Sr. Director

Landon DeCosta

Sr. Director

Landon DeCosta is a Director at Project Farma. In his role, Landon is responsible for leading multiple cross-functional, multi-disciplinary teams in large capital projects, facility builds, engineering and validation both internationally and domestically in the pharmaceutical, biotech and advanced therapy industry. 
 
Landon started his career in manufacturing at Amgen, then moved to validation, facility design and construction and to eventually providing technical and managerial leadership across various functional areas like program and project management, owner’s representation, engineering, facilities and validation.  His recent experience with Project Farma includes scaling up manufacturing for one of the first-ever advanced therapies including leading the commissioning and qualification efforts for a state-of-the-art viral vector facility build. 


Nathan Traughber

Nathan Traughber

Sr. Director

Nathan Traughber

Sr. Director

Nathan Traughber is a Director at Project Farma. With over 12 years of experience in the Biologics and Advanced Therapies industries, Nathan has a proven track record of successful engineering project management in an FDA regulated environment. This success comes from a strong multidisciplinary background in engineering, validation, quality, manufacturing and infrastructure.

In the Biologics space, Nathan has successfully implemented tens of millions of dollars in GMP engineering projects. He often served multiple simultaneous project roles such as Project Manager, Engineering Technical Lead, Qualification & Validation Lead and others as projects required.

At Project Farma, Nathan has spent the last 4 years deeply engaged in Advanced Therapies and has supported clients in various stages of clinical and commercial growth.  His strong GMP capital project background has enabled him to support strategic planning and execution of significant manufacturing expansions.


Emily Crumpton

Emily Crumpton

Marketing Manager

Emily Crumpton

Marketing Manager

Emily Crumpton is an experienced manager, board member, and philanthropist. She is a Marketing Manager at Project Farma, a Precision for Medicine Company.

Emily began her career in Human Resources at Project Farma in 2017. Her role quickly expanded to include corporate social responsibility, managing conferences and events, and growing and maintaining philanthropic partnerships.

In 2020, Precision Medicine Group acquired Project Farma, bolstering the company’s ability to offer comprehensive solutions to drug developers. In 2021, Emily stepped into the role of Marketing Manager for Project Farma’s business unit, managing marketing & brand strategy, corporate communication and event management, thought leadership opportunities, and PR & media relations. Currently, Emily is focused on managing the development and execution of corporate communication, strategic marketing partnerships, digital campaigns, and executing the company’s CARES Strategy.

With Emily’s support, the Project Farma team has grown to over 200 full time team members, 50+ philanthropic partnerships, and over 10,000 individual and company volunteer hours in 2023 alone.

Before her tenure at PF, Emily was a recruiter at a downtown Chicago staffing agency. She graduated from Northern Illinois University with a Bachelor’s in Sociology and Psychology. Emily’s commitment to philanthropy extends to various boards and memberships including the Muscular Dystrophy Association and Special Olympics of Illinois.


Danny Foody

Danny Foody

Director

Danny Foody

Director

As a member of Project Farma, Danny Foody has supported and led capital projects for several partners in the Advanced Therapies and Biologics space. Danny provides technical and quality leadership for advising start-up and established pharmaceutical companies for CMO/CDMO operational readiness capabilities. Working with Project Farma’s Technical Operations team, he provides subject matter expertise in designing, implementing, and maintaining cGMP facilities. Prior to Project Farma, Danny worked in an analytical and quality control laboratory. He earned his B.S. degree in Molecular and Cellular Biology from University of Illinois Urbana-Champaign.


Nick Weinrich

Nick Weinrich

Sr. Manager

Nick Weinrich

Sr. Manager

Nicholas Weinreich is a Senior Manager at Project Farma. In his role, Nick leads teams supporting various projects ranging from facility implementation, data integrity remediation, process implementation/modification, and equipment upgrades. These projects have ranged from Pharmaceuticals, Biotechnology, Gene and Cell Therapy, and have required expertise in Project Management, Validation, Quality, Automation, and Engineering.

With 10 years of industry experience, Nick has supported an array of clients from clinical startups to mature commercial facilities. His recent experience with PF required leading the Automation Validation workstream for a site conversion in the Gene Therapy space. Nick also supports the growth of his team members by providing technical guidance and leverages previous experience to overcome day to day challenges. He has a degree in Mechanical Engineering from the University of Colorado at Boulder.


Christian Hermanas

Christian Hermanas

Sr. Manager

Christian Hermanas

Sr. Manager

Christian Hermanas is a graduate of the University of Southern California with his background in Biochemical Engineering. Christian is one of the East Coast leads for Project Farma supporting North Carolina and the Southeast. He is biotech veteran with his background Project Engineering and Project Management. Christian has supported multiple Gene Therapy manufacturing facility design and builds ranging up to $400MM. He has also supported pre-clinical and clinical organizations as they characterize their process and prepare for commercialization scale up.


Evan Bryant

Evan Bryant

Sr. Manager

Evan Bryant

Sr. Manager

Evan Bryant is one of the East Coast leads for Project Farma supporting the Washington D.C. and Baltimore areas. He is biotech veteran with his background in Commissioning, Qualification, and Validation, and Project Management. Evan has supported multiple advanced medicine and Cell Therapy manufacturing facility builds ranging up to $440MM. He is a graduate of Michigan State University with his background in Mechanical Engineering.


Julia Taicsich

Julia Taicsich

Human Resources Manager

Julia Taicsich

Human Resources Manager

Julia Taicsich is the Human Resources Manager at Project Farma. In her role, Julia leads the Human Resources Department in recruiting, benefits administration, policy development, and company-wide initiatives including employee engagement, career development, performance management, and philanthropy. She has a degree in Psychology from Marquette University.


Kayla Fouch

Kayla Fouch

Sr. Manager

Kayla Fouch

Sr. Manager

Kayla Fouch is a Manager at Project Farma. In her role, Kayla leads teams of engineers in a wide array of projects including supporting advanced therapy facility build outs, compliance remediation, and process improvement initiatives.

With over 5 years of experience in process design, development, and testing, as well as technical learning management, Kayla has supported the PF global commitment to technical excellence through the development of industry-leading educational programs. She supports the Project Farma team as a technical lead on a broad variety of initiatives. Kayla has an undergraduate degree in Biology from Purdue University, a masters in Biotechnology and Chemical Sciences from Roosevelt University, as well as an MBA from the Quantic School of Business and Technology.


Parla Hoelter

Parla Hoelter

Manager

Parla Hoelter

Manager

Parla Hoelter is a Manager at Project Farma. In her role, she has lead teams in globalization, facility expansion, compliance, data integrity, commissioning & qualification, and automation. Parla has worked with small and large biotech and pharmaceutical companies including gene therapy startups and CMOs across the Midwest and is active in the mentorship program at Project Farma. She enjoys helping grow new talent and is chairperson of the Conference and Outreach Committee. She holds a bachelor’s in chemical engineering from Mississippi State University.


Spencer Sather

Spencer Sather

Sr. Manager

Spencer Sather

Sr. Manager

Spencer Sather is a Manager at Project Farma. With nearly a decade of biotechnology experience at companies ranging from established industry players to up-and-coming startups, Spencer has led and supported a variety of projects including QC lab buildouts, analytical method development, validation, process equipment, and computerized systems validation. He also has experience in assisting organizations identify and define key process parameters prior to manufacturing scale-up implementation.


Tony Prince

Tony Prince

Manager

Tony Prince

Manager

Tony Prince is a graduate of the University of Southern California with his background in Industrial & Systems Engineering. Tony is one of the West Coast leads for Project Farma supporting Southern California. He is Gene & Cell Therapy veteran with his background in Cleanrooms, Automation, Project Engineering, and Project Management.

Tony has supported multiple Gene & Cell Therapy manufacturing facility design and builds ranging up to $300MM. He has also supported post-facility build validation and engineering backfill at existing Cell therapy manufacturing facilities helping his clients to maintain flexibility in supplying an increasing demand for live saving therapies


Sean Terrett

Sean Terrett

Sr. Manager

Sean Terrett

Sr. Manager

Sean Terrett is a Manager for Project Farma on the East Coast. Sean is a biotech veteran with a background in project engineering and project management and has supported multiple gene and cell therapy manufacturing facility design and builds. Sean has supported pre-clinical and clinical organizations perform business case analysis whether to build manufacturing capacity internally or purchase manufacturing capacity externally for their commercial pipeline.


Ryan Limbo

Ryan Limbo

Sr. Manager

Ryan Limbo

Sr. Manager

Ryan Limbo is a Manager at Project Farma. He has supported projects in diverse roles across validation, engineering, and capital project management. With years of experience working with advanced therapy clients from preclinical through commercialization, as well as biologics and complex molecule experience with some of the industry’s largest clients, he’s grateful for the opportunity to help bring new treatments to patients.

Having implemented bench-scale to production equipment, his latest projects have focused on QMS system development, analytical equipment validation, as well as facility/utility buildout and renovation. Ryan holds a Bachelor of Science in Chemical Engineering from University of California, Davis.


Jessica Cook

Jessica Cook

Accountant

Jessica Cook

Accountant

Jessica Cook is a Staff Accountant at Project Farma. In her role, Jessica supports the accounting department in payroll, AP & AR processing, business administration and reporting, as well as team member support. With over 10+ years of accounting experience, Jessica facilitated the creation and execution of Project Farma infrastructure operation excellence.


Ravi Shah

Ravi Shah

Manager

Ravi Shah

Manager

Ravi Shah is a Manager at Project Farma. In his role, Ravi supports Project Farma’s partners to lead diverse multi-disciplinary teams and support capital projects from implementing new equipment to facility builds.

With over 10 years of experience, Ravi has supported some of Project Farma’s largest clients and projects from backfilling roles such as Process Engineer, Commissioning and Qualification Lead, to providing consulting services to develop industry leading processes. Ravi is a graduate of Purdue University with a Bachelor of Science degree in Chemical Engineering.


Austin Potthoff

Austin Potthoff

Manager

Austin Potthoff

Manager

Austin has extensive experience in capital project management and validation in the Pharmaceuticals, Medical Device, Biotechnology and Advanced Therapy Industry. With Project Farma Austin has lead and managed validation teams of 10+ team members in Project Engineering, Project Management, and Commissioning & Qualification in the pharmaceutical and biopharmaceutical industry. In addition to implementing new facility build out and qualification for complex molecule manufacturing, Austin has most recently successfully managed Tech Transfer in existing facilities for novel processes that require significant infrastructure change.


Derrick Molera

Derrick Molera

Manager

Derrick Molera

Manager

Derrick Molera is a graduate of California State University, Channel Islands with a background in Biology. He has eight years of biotech experience in a multitude of fields ranging from manufacturing, quality assurance, quality systems & compliance, document control, knowledge management, materials management, drug product labeling & packaging, and final drug product disposition.


Zachary Luce

Zachary Luce

Sr. Manager

Zachary Luce

Sr. Manager

Zachary Luce is a Manager at Project Farma and has led projects including facility start-ups, facility improvements/expansions, lab conversions, and capital equipment projects.

He has developed partner strategies for C&Q as well as managed implementation of C&Q strategies with multi-disciplinary teams including automation systems, lab instruments, single-use systems, and traditional stainless steel vessels. Zach has also overseen start-ups and expansions of labs and facilities to meet partner’s schedules and budgets. Additional support has been provided for implementation of new capital equipment and facility improvements.


Andrew Doppstadt

Andrew Doppstadt

Sr. Manager

Andrew Doppstadt

Sr. Manager

Andrew Doppstadt is a Manager at Project Farma. In his role, Andrew manages a multitude of clients through the Northeast region, leading cross functional teams in biologics, radiopharmaceuticals, and cell and gene therapy. Additionally, Andrew supports leadership efforts for all clients in the Northeast Region.

Beginning his careers in Quality Management Systems at Sanofi, Andrew transitioned into pharmaceutical consulting, delivering technical and management leadership solutions in a multitude of areas such as project management, engineering, facilities, infrastructure, process development, and quality. Andrew’s recent experience with PF includes process development and qualification strategy development for groundbreaking therapies in the Cell and Gene therapy space. Andrew has a Finance Degree and an Economics Degree from the University of New Hampshire.


Austin Dower

Austin Dower

Sr. Manager

Austin Dower

Sr. Manager

Austin Dower is a Manager at Project Farma. In his role, Austin serves as a Southeast Region lead. With a background in analytical process development and qualification, Austin shifted focus to biologics-based capital projects, led teams through traditional and risk-based validation, and managed manufacturing PMO and operational readiness teams internationally. In his more recent roles, Austin has managed manufacturing execution system (MES) implementations, and designed and managed automation designs for gene therapy builds.

Austin is a graduate of the University of North Carolina at Chapel Hill with a degree in Biology and Biochemistry.


Michael Bloom

Michael Bloom

Manager

Michael Bloom

Manager

As a member of Project Farma, Michael Bloom has leveraged his background in CQV, cleanroom design, upstream processing, and project management to support multiple gene and cell therapy cGMP, pilot, and QC facility builds across the advanced therapy space. Michael has worked with multi-disciplinary teams to develop VMPs, project charters, capacity planning analyses, and CQV strategies to ensure all planned activities meet the partner’s budget and schedule, and ensure all equipment is ready for day 1 operation. He earned his B.S. degree in Mechanical Engineering from University of Illinois Urbana-Champaign


Allison Bushman

Allison Bushman

Sr. Manager

Allison Bushman

Sr. Manager

Allison Bushman is a Sr. Consultant II at Project Farma. She is one of the leads within the Northeast region supporting the expansion of gene and cell therapy in Washington, D.C. area. Allison is a graduate of Yale University (B.S.) and University of Illinois (M.S.) with a background in Mechanical Engineering.

Allison has support multiple projects, including facility builds, development of maintenance and reliability programs, process validation, and technical transfers. Her experience enables her to support Project Farma and client teams to achieve key milestones that drive advancements in gene and cell therapy with the goal of improving the lives of patients.


Phil Baratta

Phil Baratta

Manager

Phil Baratta

Manager

Phillip Baratta is a Manager at Project Farma. Phillip has extensive experience in capital project management and validation in the Pharmaceuticals, Biotechnology and Advanced Therapy Industry. With Project Farma Phillip has 4+ years of supporting Project Farma’s largest clients  leading cross functional teams in equipment validation, LIMS implementation and data integrity remediation.  In his more recent role, Phillip manages the validation workstream for a new facility build manufacturing radioligand therapies. Phil has a degree in Health Informatics and Management from Illinois State University. 


Brian Brazill

Brian Brazill

Sr. Consultant

Brian Brazill

Sr. Consultant

Brian Brazill is a Sr. Consultant for Project Farma and is a biotech veteran with a background in process validation and project management. Brian started his career working in cold chain validation and supported successful submissions for multiple cell and gene therapies. He has worked on multinational, cross functional teams to assist in developing validation strategies and assessing risks Brian graduate of Purdue University with a background in Chemical Engineering.


Marina Lobato Cidoncha

Marina Lobato Cidoncha

Manager

Marina Lobato Cidoncha

Manager

Marina Lobato is a Sr. Consultant I at Project Farma. She started her career in the medical device industry, but since joining Project Farma she has led advanced therapy facility build CQV, including startups and CDMOs. She also has experience supporting our partners through post-facility build maintenance validation efforts. She has a degree in Biomedical Engineering from Indiana Institute of Technology


Sean McMillan

Sean McMillan

Sr. Consultant

Sean McMillan

Sr. Consultant

Sean McMillan is a Sr. Consultant II at Project Farma. In his role, Sean supports Commissioning and Qualification strategies for Project Farma’s life science partners.

With over 7+ years of experience, Sean has a diverse engineering background and experience supporting teams of various sizes. Sean has experience in engineering design, contractor coordination, and project stakeholder collaboration. He has degree in Civil Engineering from Tennessee State University


Tony Day

Tony Day

Sr. Consultant

Tony Day

Sr. Consultant

Tony Day is a Sr. Consultant at Project Farma. As a consultant, Tony supports projects in various roles across the Technical Operations continuum, including Validation, Manufacturing, Quality Control, and Capital Project Management. Tony holds a BSc in Chemistry and an MBA from Benedictine University.

With 20+ years in pharmaceutical operations, Tony’s experience in leading projects and cross-functional teams has allowed him to deliver results and bring about fundamental changes and improvements in strategy and process. He is looking forward to continuing his support of Project Farma’s efforts to drive a patient focused culture throughout the industry.


Meghna Sengupta

Meghna Sengupta

Sr. Consultant

Meghna Sengupta

Sr. Consultant

Meghna Sengupta leads quality programs and strategy development for startup and facility build projects in her role with Project Farma. She ensures that product quality and patient safety is at the foundation of each project by delivering compliant validation solutions to our clients. With her experience in project management, Meghna has led CQV and quality workstreams for some of Project Farma’s largest clients and projects.

Meghna started her career specializing in global deviation response, before moving on to a variety of roles in the pharmaceutical industry as part of cross-functional teams on capital projects driving qualification and validation efforts for multiple manufacturing facilities around the country. She earned her degree in Pharmaceutical Sciences from The Ohio State University.


Sam Scragg

Sam Scragg

Sr. Consultant

Sam Scragg

Sr. Consultant

Sam Scragg is a Sr. Consultant I at Project Farma. He is a graduate of the University of Colorado Boulder, with a degree in chemical and biological engineering and the Lockheed Martin engineering management certificate. Sam has gained diverse experience in biotech ranging from manufacturing to operations excellence and project management. Sam supports Colorado and California as a lead. He as also supported multiple site startups to develop processes, qualify equipment, and prepare for commercialization.


Purva Vaidya

Purva Vaidya

Sr. Consultant

Purva Vaidya

Sr. Consultant

Purva Vaidya is an experienced biotech and pharmaceutical Sr. Consultant I at Project Farma. She leads diverse, cross-functional teams in execution of capital projects ranging from large scale manufacturing facility builds to complex tech transfers. She has had key involvement in development and implementation of CQV strategies for both single-use advanced therapy technologies and traditional stainless steel biologics.

Purva’s contributions include supporting industry leading CDMO/CMOs implement cGMP suites for production of clinical and commercial drug product. Purva earned her B.S. and M.S. in Biomedical Engineering from Drexel University.


Craig Shaffer

Craig Shaffer

Sr. Consultant

Craig Shaffer

Sr. Consultant

Craig Shaffer a Senior Consultant at Project Farma. In his role, Craig helps lead and support cross-functional teams on a range of projects nationally and abroad. With over 5 years of experience in the biotech industry, Craig has helped bring several advanced therapies to market impacting countless patients. Craig has a degree in Chemical Engineering from University of Illinois at Chicago.


Ally Moore

Ally Moore

Senior Analyst, FP&A

Ally Moore

Senior Analyst, FP&A

Ally Moore is a Senior Analyst, FP&A at Project Farma. In her role, Ally supports corporate deliverables by being a strategic business partner with site leads through maintaining MSA’s, forecasts, internal & external reporting metrics, and providing ad-hoc analysis. With a degree in Business Management from Elmhurst College and over 10+ years of finance and accounting experience Ally has been essential in implementing and driving processes to help make Project Farma successful


Garrett Wolf

Garrett Wolf

Sr. Consultant

Garrett Wolf

Sr. Consultant

Garrett Wolf is a Senior Consultant at Project Farma. In his role, Garrett helps lead and support cross-functional teams for capital and operational-support projects that have provided hands-on experience with a wide variety of GxP systems in both the CQV and CSV work streams. Garrett has a degree in Biomedical Engineering from Wichita State University.


Brett Wolff

Brett Wolff

Manager

Brett Wolff

Manager

Brett Wolff is a Sr. Consultant I at Project Farma. In his role, Brett leads the Automation and Computer System Validation (CSV) efforts for several Advanced Therapy partners, facilitating the development and execution of validation strategies and essential cross-functional processes. In addition to his Automation experience, as a Project Manager, Brett drives Capital Project timelines, milestones, and key decisions within CQV, Supply Chain, QC, and Materials Management workstreams. He is a graduate of the University of Florida with a background in Biomedical Engineering.